• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-4800
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Pain (1994)
Event Date 10/29/2020
Event Type  malfunction  
Manufacturer Narrative
The device was returned to the apollo device analysis laboratory on 03/dec/2020.Analysis of the device is ongoing.A review of the device labeling notes the following: the risk documentation for this device establishes the occurrence ranking for the reported event "inflation" as "remote", which is defined by apollo as.02% -.49% of complaints over units sold.A review for the intragastric balloon products for the failure mode "inflation" is performed during quarterly complaint analysis meetings (cam) and has demonstrated that global balloon inflation rate remains at "remote".Therefore, apollo determined that the reported event is occurring within the range of the expected frequency and severity for this reported event, as referenced in the cam meeting slides.The current orbera® intragastric balloon system directions for use (dfu) addresses the known and anticipated potential events of "pain " and "inflation" as follows: "the physiological response of the patient to the presence of the orbera system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response." "each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms." "complications: possible complications of the use of the orbera system include: gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.Abdominal or back pain, either steady or cyclic.".
 
Event Description
Patient presented with severe pain.Balloon was found to be inflated with saline and air.Balloon was removed successfully.
 
Manufacturer Narrative
Supplement #1 medwatch submitted to the fda on 05/feb/2021.Device evaluation summary: the device was returned to the apollo device analysis laboratory (b)(6) 2020.Deflated balloon returned with brown coloration on the shell.The fill tube was not returned.A sample fill tube was inserted into the slit valve and an air leak test was performed and the balloon fully inflated; however, due to a small slit on the shell the balloon partially deflated.The partially inflated balloon was submerged in liquid and the slit valve produced bubbles signifying a leak.A syringe was used to push di water through the tubing into the shell and the flow of di water was continuous and unobstructed.The slit valve was spliced open to check for an obstruction and there are brownish particles present.Consulted with engineering and the leaking slit valve would not cause inflation of the device.The complaint could not be verified as it is uncertain how the inflation occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. capital of texas hwy
bldg 1, ste. 300
austin TX 78746
MDR Report Key11012672
MDR Text Key222127972
Report Number3006722112-2020-00124
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020619
UDI-Public(01)10811955020619(17)2022-07-29(10)AF03803
Combination Product (y/n)N
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/29/2022
Device Model NumberB-4800
Device Catalogue NumberB-4800
Device Lot NumberAF03803
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/03/2020
Initial Date Manufacturer Received 11/16/2020
Initial Date FDA Received12/15/2020
Supplement Dates Manufacturer Received12/03/2020
Supplement Dates FDA Received02/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age33 YR
Patient Weight64
-
-